Affimed GmbH

ACTIVE

Gottlieb-Daimler-Str. 2, Mannheim, Baden-Württemberg, Germanywww.affimed.comPublic51–100 employeesEstablished: 2000-01-01

Part of Affimed NV

Clinical Trials

9 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

85.7%

Phase 2

14.3%

Trial Status Distribution

Active, not recruiting

42.9%

Completed

23.8%

Recruiting

4.8%

Terminated

28.6%

Clinical Trials

Trials sponsored by this organization (21)

A Phase 1/2a study of AFM24 and Atezolizumab in patients with advanced and metastatic cancers

Phase 1

Recruiting

interventional

Apr 2024148 participants

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Phase 2

Terminated

interventional

Oct 202325 participants

First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1

Terminated

interventional

Mar 202330 participants

A Phase 1/2a study of AFM24 and Atezolizumab in patients with advanced and metastatic cancers

Phase 1

Active, not recruiting

interventional

Oct 2022148 participants

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Phase 1

Terminated

interventional

Nov 2021112 participants

A Phase 1/2a Study to Assess AFM24 in Advanced Solid Cancers

Phase 1

Active, not recruiting

Aug 2021150 participants

A Phase 1/2a study of AFM24 and Atezolizumab in patients with advanced and metastatic cancers

Phase 1

Active, not recruiting

Jul 2021165 participants

Studio per valutare la sicurezza e l'efficacia di AFM13 in pazienti con alcuni tipi di linfoma a cellule T

Phase 1

Active, not recruiting

Jan 2021145 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations